经导管主动脉瓣置换术后瓦尔萨尔瓦窦血栓的最佳抗栓治疗方案是什么？
What Is the Optimal Antithrombotic Therapy for Valsalva Thrombus Following Transcatheter Aortic Valve Replacement?
作者信息
Kato Yuta, Kawahira Yuto, Miyazaki Midori, Hirata Tetsuo, Kuwahara Go, Sugihara Makoto, Miura Shinichiro
机构信息
Department of Cardiology, Fukuoka University Hospital, Fukuoka, Japan.
Department of Clinical Laboratory and Transfusion, Fukuoka University Hospital, Fukuoka, Japan.
出版信息
JACC Case Rep. 2024 Aug 21;29(16):102455. doi: 10.1016/j.jaccas.2024.102455.
Abstract
Thrombus formation between the native sinus of Valsalva and the implanted transcatheter heart valve is a rare complication that may be associated with an increased risk for thrombotic complications. This paper presents the course of 3 cases with Valsalva thrombus, with a focus on the management of antithrombotic therapy.
摘要
在主动脉瓣窦与植入的经导管心脏瓣膜之间形成血栓是一种罕见的并发症，可能与血栓形成并发症风险增加相关。本文介绍了3例主动脉瓣窦血栓患者的病程，重点关注抗栓治疗的管理。
Zotero 插件